We are live on ! Find out more
FI

Fosun International Portfolio holdings

AUM $399M
1-Year Est. Return 16.11%
This Fund
S&P 500
This Quarter Est. Return
-8.62%
1 Year Est. Return
-16.11%
3 Year Est. Return
+16.92%
5 Year Est. Return
-0.68%
10 Year Est. Return
+98.52%
AUM
$902M
AUM Growth
-$613M
Cap. Flow
-$411M
Cap. Flow %
-45.55%
Top 10 Hldgs %
57.67%
Holding
342
New
42
Increased
40
Reduced
54
Closed
115

Top Buys

Rank Stock Value
1
AMRX icon
Amneal Pharmaceuticals
AMRX
+$6.87M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$3.2M
3
TSM icon
TSMC
TSM
+$1.88M
4
BKNG icon
Booking.com
BKNG
+$1.49M
5
WPM icon
Wheaton Precious Metals
WPM
+$1.48M

Top Sells

Rank Stock Value
1
DBRG icon
DigitalBridge
DBRG
+$33.8M
2
ARRY
Array Biopharma Inc
ARRY
+$23.1M
3
INCY icon
Incyte
INCY
+$10.1M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$9.75M
5
IOVA icon
Iovance Biotherapeutics
IOVA
+$9.33M

Sector Composition

Rank Sector Weight
1 Healthcare 16.66%
2 Industrials 5.91%
3 Financials 5.49%
4 Technology 5.04%
5 Communication Services 3.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NBRV
301
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
– –
-2,666
Closed -$1.48M
MYOK
302
DELISTED
MyoKardia, Inc. Common Stock
MYOK
– –
-81,528
Closed -$3.94M
IMMU
303
DELISTED
Immunomedics Inc
IMMU
– –
-250,433
Closed -$3.47M
MNTA
304
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
– –
-91,462
Closed -$1.13M
PTLA
305
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
– –
-74,800
Closed -$2M
PGNX
306
DELISTED
Progenics Pharmaceuticals Inc
PGNX
– –
-472,580
Closed -$2.75M
STML
307
DELISTED
Stemline Therapeutics, Inc.
STML
– –
-212,936
Closed -$3.21M
AGN
308
DELISTED
Allergan plc
AGN
– –
-3,500
Closed -$581K
RARX
309
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
– –
-108,073
Closed -$3.1M
DERM
310
DELISTED
Dermira, Inc.
DERM
– –
-425,626
Closed -$3.82M
ARQL
311
DELISTED
Arqule Inc
ARQL
– –
-221,297
Closed -$2.4M
MDCO
312
DELISTED
Medicines Co
MDCO
– –
-92,500
Closed -$3.29M
MDSO
313
DELISTED
Medidata Solutions, Inc.
MDSO
– –
-7,600
Closed -$687K
ALDR
314
DELISTED
Alder Biopharmaceuticals
ALDR
– –
-233,858
Closed -$2.64M
ARRY
315
DELISTED
Array Biopharma Inc
ARRY
– –
-498,733
Closed -$23.1M
ZGNX
316
DELISTED
Zogenix, Inc.
ZGNX
– –
-45,700
Closed -$2.18M
CTIC
317
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
– –
-459,274
Closed -$390K
CELG
318
DELISTED
Celgene Corp
CELG
– –
-22,000
Closed -$2.03M
LJPC
319
DELISTED
La Jolla Pharmaceutical Company
LJPC
– –
-416,260
Closed -$3.74M
9 10 11 12
13

Similar funds

NC
NovaPoint Capital Atlanta, Georgia $399M AUM 26.97% 1-Year Est. Return
T2I
Turim 21 Investimentos Rio De Janeiro, Brazil $399M AUM 20.13% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
IAA
Ironsides Asset Advisors Rocky Mount, North Carolina $399M AUM 13.99% 1-Year Est. Return
THL
Tillman Hartley LLC Denver, Colorado $398M AUM 16.44% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $398M AUM 23.9% 1-Year Est. Return
BWM
BCGM Wealth Management Lafayette, Indiana $398M AUM 17.85% 1-Year Est. Return
KHCM
Kettle Hill Capital Management New York $399M AUM 10.05% 1-Year Est. Return

Fosun International's Q3 2019 Portfolio in Review

As of Q3 2019, Fosun International held 342 positions worth $902M, down 40% from $1.51B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Fosun International withdrew a net $411M in Q3 2019, closing 115 positions and reducing 54 holdings. Its most notable exit was DigitalBridge, an estimated $33.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 32% a quarter earlier, followed by Industrials and Financials.

Against the trend, Fosun International opened a new position in Zoetis worth $1.24M.

  • Fosun International's largest Q3 2019 buy was Zoetis: 10,000 shares worth $1.24M.
  • Fosun International added most to Amneal Pharmaceuticals in Q3 2019, an estimated $6.87M increase.
  • Fosun International's biggest Q3 2019 reduction was BioMarin Pharmaceuticals, cutting an estimated $7.14M.
  • Fosun International fully exited DigitalBridge in Q3 2019, selling an estimated $33.8M.
  • Fosun International's ten largest holdings make up 58% of its $902M portfolio in Q3 2019.
  • Fosun International opened 42 new positions and closed 115 in Q3 2019.
  • Fosun International's portfolio value fell 40% quarter-over-quarter to $902M.

Based on Fosun International's 13F filing for Q3 2019, filed 12 Nov 2019.